4//SEC Filing
Karydas Daphne 4
Accession 0001209191-22-040376
CIK 0001664106other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 6:59 AM ET
Size
5.8 KB
Accession
0001209191-22-040376
Insider Transaction Report
Form 4
Karydas Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-17+12,500→ 12,500 totalExercise: $0.38Exp: 2032-06-17→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]The options were granted by LogicBio Therapeutics, Inc. (the "Company") pursuant to its 2018 Equity Incentive Plan, as provided under the Company's current non-employee director compensation policy.
- [F2]The options will vest in full on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Company on the vesting date.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001816952
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 6:59 AM ET
- Size
- 5.8 KB